33 Amendments of Christian EHLER related to 2011/0402(CNS)
Amendment 167 #
Proposal for a decision
Recital 7 a (new)
Recital 7 a (new)
(7a) In order to maintain and increase the Union's industrial leadership there is an urgent need to stimulate private sector research and development and innovation investment, to promote research and innovation with a business driven agenda and accelerate the development of new technologies which will underpin future businesses and economic growth. Therefore it is necessary to strongly stimulate the participation of industry in Horizon 2020, especially in Part II "Industrial leadership" and Part III "Societal challenges".
Amendment 274 #
Proposal for a decision
Annex 1 – point 1 – point 1.1 – paragraph 4
Annex 1 – point 1 – point 1.1 – paragraph 4
For the societal challenges and the enabling and industrial technologies in particular, there will be a particular emphasis on supporting activities which operate close to the end-users and the market, such as demonstration, piloting or proof-of-concept. This will also include, where appropriate, activities in support of social innovation, innovation in services and support to demand side approaches such as pre-standardisation or pre- commercial procurement, procurement of innovative solutions, standardisation and other user-cantered measures to help accelerate the deployment and diffusion of innovative products and services into the market. In addition, there will be sufficient room for bottom-up approaches and open, light and fast schemes under each of the challenges and technologies to provide Europe's best researchers, entrepreneurs and enterprises with the opportunity to put forward breakthrough solutions of their choice.
Amendment 275 #
Proposal for a decision
Annex 1 – point 1 – point 1.1 – paragraph 4 a (new)
Annex 1 – point 1 – point 1.1 – paragraph 4 a (new)
Within the societal challenges and the industrial leadership priority, a challenge- based approach should be followed, in which basic science, applied research, knowledge transfer and innovation are equally important and interlinked components. In order to ensure the appropriate balance between consensus- based and more disruptive R&D&I, at least 35% of the budget of the societal challenges and industrial leadership should follow a bottom-up logic, establishing open calls without predefined call topics. Furthermore, the right balance should be struck within the societal challenges and the enabling and industrial technologies between smaller and bigger projects, taking into account the specific sector structure, type of activity, technology and research landscape.
Amendment 304 #
Proposal for a decision
Annex 1 – point 1 – point 1.3 – introductory part
Annex 1 – point 1 – point 1.3 – introductory part
1.3. SIndustry and small and medium-sized enterprises (SMEs)
Amendment 305 #
Proposal for a decision
Annex 1 – point 1 – point 1.3 – paragraph -1 (new)
Annex 1 – point 1 – point 1.3 – paragraph -1 (new)
With its potential to make Europe truly competitive, Horizon 2020 will foster a broader participation of private companies in all parts of the programme, particularly within part II ("Industrial Leadership") and part III ("Societal Challenges"). Collaboration between academia and industry a driving force for innovation will be strengthened in order to unlock full dynamic interaction between basic research, applied research and development and demonstration activities.
Amendment 306 #
Proposal for a decision
Annex 1 – point 1 – point 1.3 – paragraph -1 a (new)
Annex 1 – point 1 – point 1.3 – paragraph -1 a (new)
In accordance with Article 18 a (new) of Horizon 2020, a Fast Track to Innovation within the specific objective 'Leadership in enabling and industrial technologies' and Part III 'Societal challenges' will provide a fast lane for projects that focus on bringing innovative ideas to the market. While being open to all types of participants, the Fast Track to Innovation is expected to attract a high number of industry participants to whom time is a crucial factor when turning an innovative idea into business success.
Amendment 516 #
Proposal for a decision
Annex 1 – section 2 – point 1 – point 1.4 – point 1.4.3 – paragraph 1
Annex 1 – section 2 – point 1 – point 1.4 – point 1.4.3 – paragraph 1
The objective is to develop platform technologies (e.g. genomics, meta- genomics, proteomics, molecular tools) triggering leadership and competitive advantage on a wide number of economic sectors. It includes aspects, such as underpinning the development of bio- resources with optimised properties and applications beyond conventional alternatives; enabling exploration, understanding and exploitation in a sustainable manner of terrestrial and marine biodiversity for novel applications; Priority support will be given to new diagnostic methods where a prevention or diagnosis for the patient in question either already exists or is likely to be developed.
Amendment 608 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.2 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.2 – paragraph 1
The development of screening programmes depends on the identification of early biomarkers of risk and of disease onset, and their deployment depends on the testing and validation of screening methods and programmes. Identifying individuals and populations at high-risk of disease will allow personalised, stratified and collective strategies for efficacious and cost effective disease prevention to be developed. In this connection, priority will be given to screening programmes where prevention or therapy for the patient concerned are available or are likely to be developed.
Amendment 619 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.6 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.6 – paragraph 1
An improved understanding of health, disease and disease processes at all ages is needed to develop new and more effective diagnostics. Innovative and existing technologies will be developed with the goal of significantly improving disease outcomes through earlier, more accurate diagnosis and by allowing for more patient-adapted treatment. In this connection, priority will be given to diagnostic methods where prevention or therapeutic measures for the patients concerned are available or are likely to be available in the near future.
Amendment 627 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.8 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.8 – paragraph 1
There is a need to support the improvement of cross-cutting support technologies for drugs, vaccines and other therapeutic approaches, including transplantation, gene and cell therapy, particularly adult stem cell therapy, umbilical cord blood cell and iPS cell therapies; to increase success in the drug and vaccine development process (including alternative methods to replace classical safety and effectiveness testing e.g. the development of new methods); to develop regenerative medicine approaches, including approaches based on stem cells; to develop improved medical and assistive devices and systems; to maintain and enhance our ability to combat communicable, rare, major and chronic diseases and undertake medical interventions that depend on the availability of effective antimicrobial drugs; and to develop comprehensive approaches to treat co-morbidities at all ages and avoid poly-pharmacy. These improvements will facilitate the development of new, more efficient, effective and sustainable treatments for disease and for the management of disability. There is a need to develop ideas in the field of regenerative medicine, particularly based on adult stem cells, umbilical cord blood cells and iPS cells.
Amendment 639 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.9 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.9 – paragraph 1
Clinical trials are the means to transfer biomedical knowledge to application in patients and support for these will be provided, as well as for the improvement of their practice. Examples include the development of better methodologies to allow trials to focus on relevant population groups, including those suffering from other concomitant diseases and/or already undergoing treatment, the determination of comparative effectiveness of interventions and solutions, as well as enhancing the use of databases and electronic health records as data sources for trials and knowledge transfer. Similarly, support for the transfer of other types of interventions such as those related to independent living into real world environments will be provided. Particular importance will be given to clinical tests in the field of rare diseases and child illnesses including those associated with premature birth.
Amendment 653 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.15 a (new)
Annex 1 – section 3 – point 1 – point 1.15 a (new)
Amendment 879 #
Proposal for a decision
Annex 1 – section 3 – point 6 – introductory part
Annex 1 – section 3 – point 6 – introductory part
6. Inclusive, innovative and secure reflective societies
Amendment 913 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.2
Annex 1 – section 3 – point 6 – point 6.2
Amendment 932 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3
Annex 1 – section 3 – point 6 – point 6.3
Amendment 934 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 1
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 1
Amendment 937 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 2
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 2
Amendment 940 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3
Amendment 942 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.1
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.1
Amendment 944 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.1 – paragraph 1
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.1 – paragraph 1
Amendment 951 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.2
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.2
Amendment 953 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.2 – paragraph 1
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.2 – paragraph 1
Amendment 955 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.3
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.3
Amendment 956 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.3 – paragraph 1
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.3 – paragraph 1
Amendment 957 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.3 – paragraph 1
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.3 – paragraph 1
Amendment 959 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.4
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.4
Amendment 960 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.4 – paragraph 1
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.4 – paragraph 1
Amendment 963 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.4 – paragraph 2
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.4 – paragraph 2
Amendment 966 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.5
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.5
Amendment 967 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.5 – paragraph 1
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.5 – paragraph 1
Amendment 969 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.5 – paragraph 2
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.5 – paragraph 2
Amendment 972 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.6
Annex 1 – section 3 – point 6 – point 6.3 – paragraph 3 – point 6.3.6
Amendment 974 #
Proposal for a decision
Annex 1 – section 3 – point 6 a (new)
Annex 1 – section 3 – point 6 a (new)